Monogenetic determinants of Alzheimer's disease: APP mutations
AM Goate - Cellular and Molecular Life Sciences CMLS, 1998 - Springer
Cellular and Molecular Life Sciences CMLS, 1998•Springer
Mutations within exons 16 and 17 of the β-amyloid precursor protein (APP) gene were the
first known cause of familial Alzheimer's disease. These mutations are rare and have been
reported in a handful of families exhibiting autosomal dominant inheritance of Alzheimer's
disease with age of onset around 50 years. In vitro and in vivo studies have demonstrated
that each of these mutations alters proteolytic processing of APP, resulting in an increase in
the production of A β 42, a highly fibrillogenic peptide, that spontaneously aggregates and …
first known cause of familial Alzheimer's disease. These mutations are rare and have been
reported in a handful of families exhibiting autosomal dominant inheritance of Alzheimer's
disease with age of onset around 50 years. In vitro and in vivo studies have demonstrated
that each of these mutations alters proteolytic processing of APP, resulting in an increase in
the production of A β 42, a highly fibrillogenic peptide, that spontaneously aggregates and …
Abstract
Mutations within exons 16 and 17 of the β-amyloid precursor protein (APP) gene were the first known cause of familial Alzheimer's disease. These mutations are rare and have been reported in a handful of families exhibiting autosomal dominant inheritance of Alzheimer's disease with age of onset around 50 years. In vitro and in vivo studies have demonstrated that each of these mutations alters proteolytic processing of APP, resulting in an increase in the production of Aβ42, a highly fibrillogenic peptide, that spontaneously aggregates and deposits in the brain. Transgenic mice carrying a mutant human APP gene also show age-dependent β-amyloid (Aβ) deposition in the brain. The rate of deposition in these mice can be modified by apolipoprotein E expression.
Springer